These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 131889)
21. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease. Wara DW; Barrett DJ; Ammann AJ; Cowan MJ Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150 [No Abstract] [Full Text] [Related]
24. In vitro effect of thymosin on T cells from immunodepressed surgical patients. Hardy MA; Freund M; Friedmann N Surgery; 1976 Aug; 80(2):238-45. PubMed ID: 1085039 [TBL] [Abstract][Full Text] [Related]
25. Can drugs increase the immune response? Kent S Geriatrics; 1977 Jul; 32(7):101-13. PubMed ID: 326618 [No Abstract] [Full Text] [Related]
26. Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms. Sakal H; Costanzi JJ; Loukas DF; Gagliano RG; Ritzmann SE; Goldstein AL Cancer; 1975 Sep; 36(3):974-6. PubMed ID: 1182684 [TBL] [Abstract][Full Text] [Related]
27. Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient. Hersh EM; Mavligit GM; Gutterman JU Med Clin North Am; 1976 May; 60(3):623-39. PubMed ID: 775211 [No Abstract] [Full Text] [Related]
29. [Role of the thymus in differentiation of cells of the lymphoid series]. Giulling EV Fiziol Zh; 1977; 23(6):847-51. PubMed ID: 338374 [No Abstract] [Full Text] [Related]
30. Immunological reconstitution of T-cell-deprived mice. I. Inability of thymosin to restore spleen cell mitogen and tumor allograft response. Primus FJ; De Martino L; MacDonald R; Hansen HJ Cell Immunol; 1978 Jan; 35(1):25-33. PubMed ID: 145898 [No Abstract] [Full Text] [Related]
31. T-cell stimulator undergoes diverse testing. Gunby P JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781 [No Abstract] [Full Text] [Related]
32. Electrophoretic characteristics and membrane receptors of lymphocytes in primary immunodeficiency diseases. Durandy A; Wioland M; Sabolovic D; Griscelli C Clin Immunol Immunopathol; 1975 Sep; 4(3):440-8. PubMed ID: 127680 [No Abstract] [Full Text] [Related]
33. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states]. Grinevich IuA; Kamenets LIa Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944 [No Abstract] [Full Text] [Related]
34. In vitro and in vivo studies with thymosin in cancer patients. Schafer LA; Goldstein AL; Gutterman JU; Hersh EM Ann N Y Acad Sci; 1976; 277(00):609-20. PubMed ID: 136916 [TBL] [Abstract][Full Text] [Related]
35. Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus. Scheinberg MA; Cathcart ES; Goldstein AL Lancet; 1975 Feb; 1(7904):424-6. PubMed ID: 48612 [TBL] [Abstract][Full Text] [Related]
36. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22. Tovo PA; Davi G; Fraceschini P; Delpiano A Thymus; 1986; 8(5):313-8. PubMed ID: 3798528 [TBL] [Abstract][Full Text] [Related]
37. Letter: Effects of thymosin on lymphoblasts. Tsukimote I; Lampkin BC N Engl J Med; 1975 Aug; 293(9):455-6. PubMed ID: 1080255 [No Abstract] [Full Text] [Related]
38. Clinical assessment of T and B lymphocyte functions. Farnes P R I Med J (1976); 1976 Feb; 59(2):51-6, 71. PubMed ID: 1082619 [No Abstract] [Full Text] [Related]
39. Thymosin therapy in the DiGeorge syndrome. Barrett DJ; Wara DW; Ammann AJ; Cowan MJ J Pediatr; 1980 Jul; 97(1):66-71. PubMed ID: 7381650 [TBL] [Abstract][Full Text] [Related]
40. [Cell-mediated immunological response in the light of new theories]. Hager-Malecka B Pediatr Pol; 1972 Sep; 47(9):1161-6. PubMed ID: 4565188 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]